Pages that link to "Q73252837"

The following pages link to Botulinum toxin A in the hemiplegic upper limb: a double-blind trial (Q73252837):

Displaying 49 items.

• Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy (UPDATE) (Q24240402) (← links)
• Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy (Q24245806) (← links)
• Effects of Extracorporeal Shock Wave Therapy on Spasticity in Patients after Brain Injury: A Meta-analysis (Q26824164) (← links)
• Functional Popliteal Artery Entrapment Syndrome: Poorly Understood and Frequently Missed? A Review of Clinical Features, Appropriate Investigations, and Treatment Options (Q30666485) (← links)
• The role of botulinus toxin type A in treatment--with special reference to children (Q33662793) (← links)
• Recommendations for the use of botulinum toxin type A in the management of cerebral palsy. (Q33831980) (← links)
• Upper limb function and deformity in cerebral palsy: a review of classification systems (Q34173052) (← links)
• Botulinum neurotoxin intramuscular chemodenervation. Role in the management of spastic hypertonia and related motor disorders. (Q34449202) (← links)
• Spasticity associated with cerebral palsy in children: guidelines for the use of botulinum A toxin (Q35039104) (← links)
• Practice parameter: pharmacologic treatment of spasticity in children and adolescents with cerebral palsy (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the (Q35065448) (← links)
• Botulinum Neurotoxin Type A (Q35562563) (← links)
• The use of botulinum toxin in pediatric disorders. (Q35568542) (← links)
• Pharmacologic management of the spastic and dystonic upper limb in children with cerebral palsy (Q35574920) (← links)
• Botulinum toxin A in the management of upper limb spasticity in cerebral palsy (Q35574924) (← links)
• Approach to the rehabilitation of spasticity and neuromuscular disorders in children (Q35638590) (← links)
• Botulinum toxin in children with cerebral palsy (Q35998686) (← links)
• Therapeutic interventions for tone abnormalities in cerebral palsy (Q36428754) (← links)
• Botulinum toxin type A injection for management of upper limb spasticity in children with cerebral palsy: a literature review. (Q36635231) (← links)
• Spastic movement disorder: impaired reflex function and altered muscle mechanics (Q36885694) (← links)
• Nonoperative management of spasticity in children (Q36890044) (← links)
• The importance of neurorehabilitation to the outcome of neuromodulation in spasticity. (Q36907030) (← links)
• Botulinum Toxin Treatment on Upper Limb Function in School Age Children With Bilateral Spastic Cerebral Palsy: One Year Follow-up (Q37018809) (← links)
• Muscle weakness and lack of reflex gain adaptation predominate during post-stroke posture control of the wrist. (Q37320529) (← links)
• Intramuscular Neurotrophin-3 normalizes low threshold spinal reflexes, reduces spasms and improves mobility after bilateral corticospinal tract injury in rats. (Q37351559) (← links)
• Effectiveness of botulinum toxin A for upper and lower limb spasticity in children with cerebral palsy: a summary of evidence (Q37367957) (← links)
• Botulinum Toxin A Injections to the Upper Limbs in Children With Cerebral Palsy: Duration of Effect (Q37798600) (← links)
• Pharmacologic Treatment of Spasticity in Children (Q37823731) (← links)
• Upper limb motion analysis in children with hemiplegic cerebral palsy: proximal kinematic changes after distal botulinum toxin or surgical treatments (Q38555397) (← links)
• Botulinum toxin A in orthopedic pain therapy (Q39373044) (← links)
• Pendulum test in cerebral palsy (Q40758879) (← links)
• Neurologic uses of botulinum neurotoxin type A. (Q42086848) (← links)
• Botulinum toxin use as an adjunctive modality in a patient with multiple flexor tendon ruptures (Q42418542) (← links)
• The use of botulinum toxin in paediatric hypertonia. (Q43076612) (← links)
• Electrical stimulation in the management of spastic deformity. (Q51803169) (← links)
• Neurorehabilitation of children with cerebral palsy (Q61441091) (← links)
• Cerebral Palsy (Q73239058) (← links)
• [Botulinum toxin and spinal cord injury] (Q73827356) (← links)
• [Botulinum toxin type A in children: evaluation of indications with a review of the literature] (Q73827384) (← links)
• Double-blind study of botulinum A toxin injections into the gastrocnemius muscle in patients with cerebral palsy (Q78199101) (← links)
• [Treatment of the motor cerebral palsy child with botulinum toxin A: mode of action, injection places in management] (Q78393966) (← links)
• Functional and cosmetic outcome of surgery for cerebral palsy in the upper limb (Q79245951) (← links)
• Brachial plexus dorsal rhizotomy in hemiplegic cerebral palsy (Q79245955) (← links)
• Percutaneous radiofrequency lesion adjacent to the dorsal root ganglion in the treatment of spasticity and pain in children with cerebral palsy (Q79407131) (← links)
• Cerebral palsy (Q80093084) (← links)
• Low-dose/high-concentration localized botulinum toxin A improves upper limb movement and function in children with hemiplegic cerebral palsy (Q82576884) (← links)
• Localization of motor entry points and terminal intramuscular nerve endings of the musculocutaneous nerve to biceps and brachialis muscles (Q84586070) (← links)
• Effect of botulinum toxin type-A in spasticity and functional outcome of upper limbs in cerebral palsy (Q89883113) (← links)
• Botulinum Toxin A Injection in Treatment of Upper Limb Spasticity in Children with Cerebral Palsy: A Systematic Review of Randomized Controlled Trials (Q90734688) (← links)
• Botulinum Toxin in the Management of Children with Cerebral Palsy (Q93140830) (← links)